Myotonic dystrophy type 1
Dystrophia myotonica · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
An autosomal dominant multisystem disorder from a CTG repeat expansion in DMPK, causing distal weakness, myotonia, cataracts, cardiac conduction disease and endocrine dysfunction. Cardiac and respiratory surveillance are central as conduction block and sudden death are major risks.
Red flags
- Syncope or documented conduction block (sudden death risk)
- Respiratory failure or severe sleep apnoea
- Anaesthetic exposure without precautions
- Rapid cardiac or respiratory deterioration
- Congenital myotonic dystrophy in offspring
Assessment
Differential diagnosis
- Myotonic dystrophy type 2 (proximal, milder)
- Non-dystrophic myotonias (channelopathies)
- Limb-girdle muscular dystrophy
- Inclusion body myositis
- Motor neuron disease
- Facioscapulohumeral dystrophy
Investigations
- Genetic testing for DMPK CTG repeat expansion
- ECG and Holter monitoring (conduction disease, arrhythmia)
- Echocardiogram
- EMG (myotonic discharges)
- Pulmonary function and sleep study (respiratory/diaphragm involvement)
- Slit-lamp for cataracts, glucose and thyroid function
Management
- Recognise the characteristic facial weakness, grip myotonia, frontal balding and distal wasting
- Confirm with DMPK genetic testing
- Perform baseline and regular cardiac surveillance with ECG and Holter
- Refer for pacemaker/defibrillator if conduction disease identified
- Assess respiratory and diaphragm function and screen for sleep-disordered breathing
- Treat symptomatic myotonia if functionally limiting
- Manage daytime somnolence with stimulants where appropriate
- Screen for and manage cataracts, diabetes and hypothyroidism
- Counsel on anaesthetic risks and anticipation in offspring
- Provide genetic counselling and multidisciplinary follow-up
Drugs & doses
Mexiletine 150-200 mg PO TDS for symptomatic myotonia (with cardiac monitoring)
Modafinil 100-400 mg PO daily for hypersomnolence
No disease-modifying therapy currently available
Avoid depolarising muscle relaxants and caution with anaesthesia
Disposition
Specialist neuromuscular clinic with cardiology and respiratory surveillance. Genetic counselling. Low threshold for cardiac device referral.
Complications & pitfalls
- Sudden cardiac death from conduction disease/arrhythmia
- Respiratory failure and aspiration
- Anaesthetic complications
- Diabetes and cataracts
- Progressive disability and anticipation in subsequent generations
Exam pearls
- Cardiac conduction disease can cause sudden death even with mild muscle symptoms; monitor ECG regularly
- Anticipation means offspring can be more severely affected (congenital form)
- Patients are at high anaesthetic risk; flag before any surgery
- Daytime somnolence is common and treatable
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.